Genomic transposable elements (TEs) comprise nearly half of the human genome. The expression 29 of TEs is considered potentially hazardous, as it can lead to insertional mutagenesis and genomic 30 instability. However, recent studies have revealed that TEs are involved in immune-mediated cell 31 clearance. Hypomethylating agents can increase the expression of TEs in cancer cells, inducing 'viral 32 mimicry', causing interferon signalling and cancer cell killing. To investigate the role of TEs in the 33 pathogenesis of acute myeloid leukaemia (AML), we studied TE expression in several cell fractions of 34 AML while tracking its development (pre-leukemic haematopoietic stem cells, leukemic stem cells 35 [LSCs], and leukemic blasts). LSCs, which are resistant to chemotherapy and serve as reservoirs for 36 relapse, showed significant suppression of TEs and interferon pathways. Similarly, high-risk cases of 37 myelodysplastic syndrome (MDS) showed far greater suppression of TEs than low-risk cases. We
Introduction

45
Transposable elements (TEs) have been mostly considered detrimental because of their 46 inherent mobile nature. Their expression can lead to insertional mutagenesis, chromosomal rearrangements, and genomic instability, potentially contributing to cancer development [1] [2] [3] [4] . TEs have retrotransposons ( Figure 1A) . The most dysregulated TE types in LSCs were Alu, ERV1, ERVL, ERVK, 94 and LTR retrotransposons, all of which showed significant suppression (Table 1) .
95
We further analysed the dysregulation of TEs in individual AML samples, while tracking the stages 96 of AML. We found that specific TE types were dysregulated, with LSCs showing significant 97 suppression of Alu, ERV3. ERVK, ERVL, and LTR retrotransposons ( Figure 1C, Supplement Figure 2 ).
98
We did not observe significant suppression of LINE1 in LSCs. These results suggested that TEs were 99 dysregulated during AML development, with LSCs showing significant suppression of specific TE 100 types.
101
LSCs show suppression of interferon pathways 102
LSCs are known to be resistant to treatment and serve as potential sources of relapse for AML,
103
although the mechanisms behind this resilience are not fully understood 22 . Expression of TEs is known 104 to activate a viral recognition pathway, which causes interferon signalling and immune-mediated cell 105 clearance 16, 17 . Because LSCs showed suppressed TE expression, we investigated whether this TE viral RNA) 23 . Consistent with this finding, we also observed that NFκB pathways were more 122 suppressed in pHSCs than Blasts (Blasts and pHSCs showed similar expression of TEs)
123
(Supplemental Figure 4) . These findings suggested that both LSCs and pHSCs showed suppression 124 of NFκB and immune-related pathways, compared to Blasts. LSCs showed suppressed TE expression 125 and pHSCs showed high expression of EVI-1. Figure 4 . The coding genes were first clustered based on their co-expression to form specific modules.
138
Each module contained unique set of genes that were likely co-regulated and had functional 139 similarities. For example, module 26 contains many RNA helicase genes (Supplement Figure 5 ). We 140 correlated these modules to the expression of specific TE types and found that some modules were 141 positively or negatively correlated with the expression of specific TE types. We performed a pathway comparing Blasts to LSCs. We identified modules that showed activation (modules 3, 5, 13, 14, 17 144 and 41) and suppression (22, 24, 26, 29, 30, 39 and 46) Figure 5A ). High-risk MDS specifically showed 163 suppression of Type 1 interferon genes, which are known to be activated by viral RNA ( Figure 5B ).
164
Inflammation-related genes ( Figure 5C To further characterise the association between coding genes and TE expression, we created in the accessible regions. These findings suggested that the suppression of TEs in LSCs was likely 194 not due to increased heterochromatin.
195
Because LSCs showed suppressed TE expression despite having more accessible chromatin,
196
we investigated other pathways that could regulate TE expression. A major mechanism for regulating 197 TEs involves their post-transcriptional degradation 28-30 . We analysed genes known to suppress TEs . This protein was also seen upregulated in high-risk MDS cases and 215 LSCs ( Figure 7A and B).
216
RNA helicases are known to bind to and degrade TE post-transcriptionally 28, 29, 37-40 . We found 217 significant upregulation of the DExH class of RNA helicases (DHX) in high-risk MDS cases ( Figure 7C and Supplement figure 8 reported in cancer 41 . We speculated that the expression of TEs could be a potential mechanism for 230 immune-mediated elimination of cancer cells.
231
Hypomethylating agents have been found to be useful for treating AML and MDS, and recent 232 studies have reported that the activation of TEs with the subsequent immune activation was important 233 for their efficacy against cancers 16, 17 . Here, we demonstrated that these mechanisms likely operated 234 naturally during cancer development and progression to enable immune-mediated control of AML and short lived, they probably did not evolve mechanisms to escape immune-mediated attacks. We 244 speculate that LSCs are a subset of Blasts with the ability to evade immune recognition.
245
pHSCs, despite having similar expression levels of TEs as Blasts, also showed suppression of 246 inflammatory pathways that prevent the activation of immune signalling. EVI-1, which is known to 247 suppress NFκB, was uniquely over-expressed in pHSCs, suggesting that there exists distinct genes 
259
Our analysis that correlated the expression of coding gene networks to the expression of TE 260 types revealed an association between inflammatory pathways to SINE and LTR families and an anti-261 association with LINE1. Among the types of TEs, LINE1 is known to have the highest activity of 262 retrotranspositioning and thus has the most potential to cause genomic instability. Hence, LSCs might 263 have co-opted to evolve by suppressing the inflammation-inducing TE classes, while retaining the 264 expression of LINE1, which could potentiate genomic instability and hence clonal evolution.
265
We found high expression of several 
